Efficacy and safety over 2 years of exenatide plus dapagliflozin in the DURATION-8 study: a multicenter, double-blind, phase 3, randomized controlled trial
Track everything, but do not obsess over the scale Weekly weigh-ins at the same time of day, same conditions, provide the most useful trend data
With consistent care and the right support, regrowth is typically achievable
USD 39.95 Prices may be subject to local taxes which are calculated during checkout Similar content being viewed by others Change history 28 May 2025 A Correction to this paper has been published: References Drucker, D
Maintenance strategy The goal is durable weight loss
Start your intake Where GLP-1 Patches Stand in Clinical Development GLP-1 receptor agonist patches are not yet available as approved medications in the United States